4//SEC Filing
Patel Chirag K. 4
Accession 0001209191-23-016930
CIK 0001723128other
Filed
Mar 6, 7:00 PM ET
Accepted
Mar 7, 6:00 PM ET
Size
6.2 KB
Accession
0001209191-23-016930
Insider Transaction Report
Form 4
Patel Chirag K.
DirectorPresident & Co-CEO
Transactions
- Award
Performance-Based Restricted Stock Units
2023-03-03+733,944→ 733,944 total→ Class A Common Stock (733,944 underlying)
Footnotes (2)
- [F1]Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.
- [F2]Represents a performance-based restricted stock unit grant of 366,972 target shares. The performance-based restricted stock units are scheduled to vest based on the Issuer's Class A Common Stock achieving certain average closing price per share targets at the end of the three-year performance period. The number of shares that would be received upon vesting, if any, may vary from 0% to 200% of the target number. The number of performance-based restricted stock units reported in the table above represents the maximum number of shares issuable under the award. Any earned performance-based restricted stock units vest in full on February 28, 2026, the last day of the performance period.
Documents
Issuer
Amneal Pharmaceuticals, Inc.
CIK 0001723128
Entity typeother
Related Parties
1- filerCIK 0001738701
Filing Metadata
- Form type
- 4
- Filed
- Mar 6, 7:00 PM ET
- Accepted
- Mar 7, 6:00 PM ET
- Size
- 6.2 KB